# PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk

> **NCT01314313** · NA · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 2032 (actual)

## Conditions studied

- Symptomatic Severe Aortic Stenosis

## Interventions

- **DEVICE:** TAVR Implantation with SAPIEN XT
- **DEVICE:** SAVR Implantation

## Key facts

- **NCT ID:** NCT01314313
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2016-01
- **Final completion:** 2024-01-17
- **Target enrollment:** 2032 (ACTUAL)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01314313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01314313, "PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01314313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*